98%
921
2 minutes
20
Purpose: We conducted an observational study to investigate the opinions of neurologists and psychiatrists all around the world who are taking care of patients with seizures [epilepsy and functional seizures (FS)].
Methods: Practicing neurologists and psychiatrists from around the world were invited to participate in an online survey. On 29th September 2022, an e-mail including a questionnaire was sent to the members of the International Research in Epilepsy (IR-Epil) Consortium. The study was closed on 1st March 2023. The survey, conducted in English, included questions about physicians' opinions about FS and anonymously collected data.
Results: In total, 1003 physicians from different regions of the world participated in the study. Both neurologists and psychiatrists identified "seizures" as their preferred term. Overall, the most preferred modifiers for "seizures" were "psychogenic" followed by "functional" by both groups. Most participants (57.9%) considered FS more difficult to treat compared to epilepsy. Both psychological and biological problems were considered as the underlying cause of FS by 61% of the respondents. Psychotherapy was considered the first treatment option for patients with FS (79.9%).
Conclusion: Our study represents the first large-scale attempt of investigating physicianś attitudes and opinions about a condition that is both frequent and clinically important. It shows that there is a broad spectrum of terms used by physicians to refer to FS. It also suggests that the biopsychosocial model has gained its status as a widely used framework to interpret and inform clinical practice on the management of patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.yebeh.2023.109292 | DOI Listing |
Wien Klin Wochenschr
September 2025
Department of Neurology, Medical University of Vienna, Vienna, Austria.
Background: Disease-modifying therapies with amyloid-antibodies will soon be available for patients with early Alzheimer's disease, which necessitates diagnostic and therapeutic resources in hospital and outpatient settings.
Methods: The Austrian Alzheimer Society developed an online questionnaire to survey Austrian hospital-based departments of neurology and psychiatry regarding resources for amyloid-antibody therapies.
Results: Between May and October 2023, 30 out of 41 neurology (73%) and 12 out of 33 psychiatry departments (36%) responded.
Dement Neuropsychol
August 2025
Université de Lorraine, Archives Henri Poincaré, Nancy, Grand Est, France.
One year after the German-American neurologist and psychiatrist Kurt Goldstein had died, the Soviet-Russian neurologist Alexander R. Luria published a brief obituary-like article in which he praised Goldstein's 1925 lecture () as founding text of neuropsychology. Some reasons given by Luria for praising Goldstein's paper, however, seem unclear.
View Article and Find Full Text PDFPLoS One
August 2025
Department of Anorectal Surgery, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Introduction: Up to 50% of adult patients with epilepsy experience comorbid depression or anxiety, complicating post-treatment recovery and requiring tailored outcome assessment. No core outcome set (COS) exists for this dual-diagnosis population, unlike broader epilepsy COSs or quality-of-life COSs for drug-resistant epilepsy, which do not prioritize mental health comorbidities. This protocol outlines the development of a standardized COS to evaluate post-treatment recovery in adults with epilepsy and comorbid depression or anxiety, using the International Classification of Functioning, Disability, and Health (ICF) framework to ensure a biopsychosocial perspective.
View Article and Find Full Text PDFFront Dent Med
August 2025
Department of Orthodontics, University at Buffalo, Buffalo, NY, United States.
Background: Functional Movement Disorder (FMD) is a neurological condition involving involuntary movements without structural brain or nerve damage. It can significantly affect the craniofacial region, disrupting facial and oral motor functions and complicating dental and orthodontic care. This narrative review outlines the clinical presentation of FMD, emphasizing its relevance in orthodontics and offering a clinical management guide.
View Article and Find Full Text PDFHealthc Q
May 2025
Claire de Oliveira, is a senior health economist at the Centre for Addiction and Mental Health (CAMH) in Toronto, ON, and an associate professor at the IHPME at the University of Toronto.
People living with dementia require care from a variety of health professionals and in different settings to optimize their quality of life. A phase-based approach to costing health system use supports our understanding of the longitudinal costs of care through disease progression at a population level. This report estimates five-year and phase-based net health system costs of dementia.
View Article and Find Full Text PDF